Last edition
News about "Etripamil"
Milestone's Etripamil Nasal Spray Wins China NMPA Approval for PSVT
Milestone Pharmaceuticals’ etripamil nasal spray receives China NMPA approval for PSVT, triggering a USD 2 million payment and expanding access in Greater China.
Etripamil | 05/09/2026 | By News Bureau
3 NODE - 302 data provided by Milestone Pharma
Milestone Pharma presents data from phase 3 NODE-302 study of etripamil to treat paroxysmal supraventricular tachycardia
Etripamil | 03/05/2022 | By Sudeep Soparkar | 735
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy